Pyxis Oncology, Inc. — Form D
Pyxis Oncology, Inc. of Cambridge, MA, a company, filed a Form D exempt-offering notice with the SEC on 2019-07-12. The offering totals $22.0M, of which $22.0M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2019-07-12
- Form: D
- Accession: 0001782223-19-000001
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $22.0M
- Amount sold: $22.0M
- Remaining: $1
- Investors: 9
- Date of first sale: 2019-06-28
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-344177
Issuer
- Name: Pyxis Oncology, Inc.
- CIK: 0001782223
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 35 Cambridgepark Drive, Cambridge, MA, 02140
- Phone: (617) 351-2575
Officers, directors & promoters (13)
| Name | Role | Location |
|---|
| Jak Knowles | Director | Berkeley, CA |
| Geeta Vemuri | Director | Waltham, MA |
| Christoph Westphal | Director | CAMBRIDGE, MA |
| David Steinberg | Executive Officer | Boston, MA |
| David Steinberg | Director | Boston, MA |
| John Flavin | Director | Chicago, IL |
| Lucio Iannone | Director | Watertown, MA |
| Robert Crane | Executive Officer | Cambridge, MA |
| Christopher O?Donnell | Director | Cambridge, MA |
| Gotham Makker | Director | Cambridge, MA |
| Lara Sullivan | Director | Cambridge, MA |
| Lara Sullivan | Executive Officer | Cambridge, MA |
| Christian Schetter | Director | Cambridge, MA |
Other filings by this issuer (1)
More